Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Liabilities and Shareholders Equity (2023 - 2025)

Fractyl Health's Liabilities and Shareholders Equity history spans 3 years, with the latest figure at $121.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 12.33% year-over-year to $121.4 million, compared with a TTM value of $380.7 million through Dec 2025, down 30.14%, and an annual FY2025 reading of $121.4 million, up 12.33% over the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $121.4 million at Fractyl Health, up from $114.3 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $163.5 million in Q1 2024, with the low at $62.0 million in Q2 2025.
  • Average Liabilities and Shareholders Equity over 3 years is $111.3 million, with a median of $114.3 million recorded in 2025.
  • Year-over-year, Liabilities and Shareholders Equity skyrocketed 41.81% in 2024 and then crashed 57.66% in 2025.
  • Tracing GUTS's Liabilities and Shareholders Equity over 3 years: stood at $76.2 million in 2023, then skyrocketed by 41.81% to $108.1 million in 2024, then rose by 12.33% to $121.4 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Liabilities and Shareholders Equity are $121.4 million (Q4 2025), $114.3 million (Q3 2025), and $62.0 million (Q2 2025).